Search results
Psoriasis: Features That May Affect Biologic Rx Outcomes
Medscape· 5 days agoSeveral clinical characteristics were negatively associated with responses to biologics in a...
Certain Clinical Factors Tied to Poor Response to Biologics for Psoriasis
MedPage Today· 5 days agoPrevious exposure to biologics, higher BMI, smoking all negatively linked to response
Psoriasis study shows high level of arthritis symptoms in patients
Medical Xpress· 5 days agoThe study led by researchers at the Universities of Oxford, University College Dublin and supported...
FDA Approves Skyrizi for Ulcerative Colitis
Medscape· 4 days agoThe approval is the fourth indication for the anti–interleukin 23 monoclonal antibody after approval for Crohn's disease, psoriatic arthritis, and plaque...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks via Yahoo Finance· 4 days agoIn addition, immune system irregularities, higher diagnosis rates, increased focus on early...
Yale dermatologist points to link between skin con | Newswise
Newswise· 3 days agoDr. Jeffrey Cohen, Assistant Professor and Director of the Psoriasis Treatment Program at Yale...
The Best LED Face Masks To Improve Wrinkles And Acne, According To Dermatologists
Women's Health via Yahoo News· 3 days agoThe best FDA-approved LED light therapy face masks, per dermatologists and editors, have benefits...
Barstool's Dave Portnoy had basal cell carcinoma removed. Experts explain the skin cancer's risks,...
Yahoo Life Style via AOL· 3 days ago“In terms of prognosis and treatment outcomes, basal cell carcinoma is often considered the least...
Study led by UChicago Medicine physician finds new | Newswise
Newswise· 6 days agoA medication used for psoriasis and psoriatic arthritis is proving to be an effective treatment for moderate to severe ulcerative colitis in the findings ...
Amgen Inc. (NASDAQ:AMGN) Given Average Recommendation of “Moderate Buy” by Analysts
ETF DAILY NEWS· 3 days agoAmgen Inc. (NASDAQ:AMGN – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twenty-one brokerages that are presently covering the stock, Marketbeat Ratings ...